Bladder cancer: 2017 and beyond

por Kamat, Ashish M.
Publicado 2017

Bladder Cancer Guidelines: Let Not the Cure Be Worse than the Disease

por Kamat, Ashish M.
Publicado 2021

Advances in risk stratification of bladder cancer to guide personalized medicine

por Matulay, Justin T., Kamat, Ashish M.
Publicado 2018

NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

por Gupta, Shilpa, Kamat, Ashish M.
Publicado 2020

Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

por Gupta, Shilpa, Kamat, Ashish M.
Publicado 2020

Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer

por Agarwal, Piyus K., Kamat, Ashish M.
Publicado 2008

Optimal timing of chemotherapy and cystectomy

por Karam, Jose A, Kamat, Ashish M
Publicado 2010

Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination

por Jinesh G., Goodwin, Kamat, Ashish M.
Publicado 2012

RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program

por Jinesh, Goodwin G, Kamat, Ashish M
Publicado 2017

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin

por Li, Roger, Gilbert, Scott M., Kamat, Ashish M.
Publicado 2020

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease

por Li, Roger, Sylvester, Richard, Dinney, Colin P., Kamat, Ashish M.
Publicado 2017

Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 – what’s old is new again?

por O'Connor, Ellen, Teh, Jiasian, Kamat, Ashish M, Lawrentschuk, Nathan
Publicado 2020

Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients

por Li, Roger, Amrhein, John, Cohen, Zvi, Champagne, Monique, Kamat, Ashish M.
Publicado 2017

Novel PKC-ζ to p47(phox) interaction is necessary for transformation from blebbishields

por Jinesh, Goodwin G., Taoka, Rikiya, Zhang, Qiang, Gorantla, Siddharth, Kamat, Ashish M.
Publicado 2016

Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells

por TAKEUCHI, HISASHI, MMEJE, CHINEDU O., JINESH, GOODWIN G., TAOKA, RIKIYA, KAMAT, ASHISH M.
Publicado 2015

The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis

por Kamat, Ashish M., Cookson, Michael, Witjes, J. Alfred, Stenzl, Arnulf, Grossman, H. Barton
Publicado 2016

New discoveries in the molecular landscape of bladder cancer

por Li, Roger, Choi, Woonyoung, Ferguson 3rd, J.E., Metcalfe, Michael J., Kamat, Ashish M.
Publicado 2016

Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis

por Jinesh, Goodwin G., Manyam, Ganiraju C., Mmeje, Chinedu O., Baggerly, Keith A., Kamat, Ashish M.
Publicado 2017

New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21–23, 2017

por Black, Peter C., Goebell, Peter J., Kamat, Ashish M., Nawroth, Roman, Schmitz-Dräger, Bernd J.
Publicado 2018

COVID-19 and Bacillus Calmette-Guérin: What is the Link?

por Hegarty, Paul K., Sfakianos, John P., Giannarini, Gianluca, DiNardo, Andrew R., Kamat, Ashish M.
Publicado 2020